NCT02367937View on ClinicalTrials.gov

PRC-4016 (Icosabutate) Phase I Drug-drug Interaction Study

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Healthy
Interventions
DRUG

PRC-4016 (icosabutate)

"Midazolam, omeprazole, flurbiprofen and simvastatin interaction with PRC-4016. Detailed description under Study description"

Trial Locations (1)

LS2 9LH

Covance Clinical research Unit (CRU) Ltd,Springfield House, Hyde street, Leeds

Sponsors

Lead Sponsor

Pronova BioPharma
All Listed Sponsors
lead

Pronova BioPharma

INDUSTRY